162 related articles for article (PubMed ID: 12419585)
1. HMGIC alterations in smooth muscle tumors of soft tissues and other sites.
Hisaoka M; Sheng WQ; Tanaka A; Hashimoto H
Cancer Genet Cytogenet; 2002 Oct; 138(1):50-5. PubMed ID: 12419585
[TBL] [Abstract][Full Text] [Related]
2. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
3. Gene fusion involving HMGIC is a frequent aberration in uterine leiomyomas.
Mine N; Kurose K; Nagai H; Doi D; Ota Y; Yoneyama K; Konishi H; Araki T; Emi M
J Hum Genet; 2001; 46(7):408-12. PubMed ID: 11450849
[TBL] [Abstract][Full Text] [Related]
4. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
[TBL] [Abstract][Full Text] [Related]
5. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
[TBL] [Abstract][Full Text] [Related]
6. MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors.
Markowski DN; Huhle S; Nimzyk R; Stenman G; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2013 Mar; 52(3):297-304. PubMed ID: 23225304
[TBL] [Abstract][Full Text] [Related]
7. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
8. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
Gattas GJ; Quade BJ; Nowak RA; Morton CC
Genes Chromosomes Cancer; 1999 Aug; 25(4):316-22. PubMed ID: 10398424
[TBL] [Abstract][Full Text] [Related]
9. Three aberrant splicing variants of the HMGIC gene transcribed in uterine leiomyomas.
Kurose K; Mine N; Iida A; Nagai H; Harada H; Araki T; Emi M
Genes Chromosomes Cancer; 2001 Feb; 30(2):212-7. PubMed ID: 11135440
[TBL] [Abstract][Full Text] [Related]
10. Do leiomyomas of deep soft tissue exist? An analysis of highly differentiated smooth muscle tumors of deep soft tissue supporting two distinct subtypes.
Billings SD; Folpe AL; Weiss SW
Am J Surg Pathol; 2001 Sep; 25(9):1134-42. PubMed ID: 11688572
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva.
Nucci MR; Weremowicz S; Neskey DM; Sornberger K; Tallini G; Morton CC; Quade BJ
Genes Chromosomes Cancer; 2001 Oct; 32(2):172-6. PubMed ID: 11550285
[TBL] [Abstract][Full Text] [Related]
12. Fusion of a sequence from HEI10 (14q11) to the HMGIC gene at 12q15 in a uterine leiomyoma.
Mine N; Kurose K; Konishi H; Araki T; Nagai H; Emi M
Jpn J Cancer Res; 2001 Feb; 92(2):135-9. PubMed ID: 11223542
[TBL] [Abstract][Full Text] [Related]
13. Inguinal smooth muscle tumors in women-a dichotomous group consisting of Müllerian-type leiomyomas and soft tissue leiomyosarcomas: an analysis of 55 cases.
Patil DT; Laskin WB; Fetsch JF; Miettinen M
Am J Surg Pathol; 2011 Mar; 35(3):315-24. PubMed ID: 21297441
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
16. Evidence for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma.
Takahashi T; Nagai N; Oda H; Ohama K; Kamada N; Miyagawa K
Genes Chromosomes Cancer; 2001 Feb; 30(2):196-201. PubMed ID: 11135437
[TBL] [Abstract][Full Text] [Related]
17. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.
Conconi D; Redaelli S; Lissoni AA; Cilibrasi C; Perego P; Gautiero E; Sala E; Paderno M; Dalprà L; Landoni F; Lavitrano M; Roversi G; Bentivegna A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557274
[TBL] [Abstract][Full Text] [Related]
20. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
